Defibrotide Therapy for SARS-CoV-2 ARDS.
Saved in:
| Title: | Defibrotide Therapy for SARS-CoV-2 ARDS. |
|---|---|
| Authors: | Frame D; Blood and Marrow Transplant Program, Michigan Medicine, Ann Arbor, MI; Department of Clinical Pharmacy, Michigan Medicine, Ann Arbor, MI., Scappaticci GB; Blood and Marrow Transplant Program, Michigan Medicine, Ann Arbor, MI; Department of Clinical Pharmacy, Michigan Medicine, Ann Arbor, MI., Braun TM; Department of Biostatistics, University of Michigan School of Public Health, Ann Arbor, MI., Maliarik M; Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Michigan Medicine, Ann Arbor, MI., Sisson TH; Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Michigan Medicine, Ann Arbor, MI., Pipe SW; Division of Pediatric Hematology-Oncology, Department of Pediatrics, Michigan Medicine, Ann Arbor, MI., Lawrence DA; Department of Cardiovascular Medicine, Department of Internal Medicine, Michigan Medicine, Ann Arbor, MI., Richardson PG; Division of Hematologic Malignancies, Department of Medical Oncology, Dana Farber Cancer Institute, Harvard Medical School, Boston, MA., Holinstat M; Division of Pharmacology, University of Michigan Medical School, Ann Arbor, MI., Hyzy RC; Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Michigan Medicine, Ann Arbor, MI., Kaul DR; Division of Infectious Disease, Department of Internal Medicine, Michigan Medicine, Ann Arbor, MI., Gregg KS; Division of Infectious Disease, Department of Internal Medicine, Michigan Medicine, Ann Arbor, MI., Lama VN; Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Michigan Medicine, Ann Arbor, MI., Yanik GA; Blood and Marrow Transplant Program, Michigan Medicine, Ann Arbor, MI; Division of Pediatric Hematology-Oncology, Department of Pediatrics, Michigan Medicine, Ann Arbor, MI. Electronic address: gyanik@med.umich.edu. |
| Source: | Chest [Chest] 2022 Aug; Vol. 162 (2), pp. 346-355. Date of Electronic Publication: 2022 Apr 09. |
| Publication Type: | Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Elsevier Country of Publication: United States NLM ID: 0231335 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1931-3543 (Electronic) Linking ISSN: 00123692 NLM ISO Abbreviation: Chest Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 35413279 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Defibrotide Therapy for SARS-CoV-2 ARDS. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Frame+D%22">Frame D</searchLink>; Blood and Marrow Transplant Program, Michigan Medicine, Ann Arbor, MI; Department of Clinical Pharmacy, Michigan Medicine, Ann Arbor, MI.<br /><searchLink fieldCode="AU" term="%22Scappaticci+GB%22">Scappaticci GB</searchLink>; Blood and Marrow Transplant Program, Michigan Medicine, Ann Arbor, MI; Department of Clinical Pharmacy, Michigan Medicine, Ann Arbor, MI.<br /><searchLink fieldCode="AU" term="%22Braun+TM%22">Braun TM</searchLink>; Department of Biostatistics, University of Michigan School of Public Health, Ann Arbor, MI.<br /><searchLink fieldCode="AU" term="%22Maliarik+M%22">Maliarik M</searchLink>; Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Michigan Medicine, Ann Arbor, MI.<br /><searchLink fieldCode="AU" term="%22Sisson+TH%22">Sisson TH</searchLink>; Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Michigan Medicine, Ann Arbor, MI.<br /><searchLink fieldCode="AU" term="%22Pipe+SW%22">Pipe SW</searchLink>; Division of Pediatric Hematology-Oncology, Department of Pediatrics, Michigan Medicine, Ann Arbor, MI.<br /><searchLink fieldCode="AU" term="%22Lawrence+DA%22">Lawrence DA</searchLink>; Department of Cardiovascular Medicine, Department of Internal Medicine, Michigan Medicine, Ann Arbor, MI.<br /><searchLink fieldCode="AU" term="%22Richardson+PG%22">Richardson PG</searchLink>; Division of Hematologic Malignancies, Department of Medical Oncology, Dana Farber Cancer Institute, Harvard Medical School, Boston, MA.<br /><searchLink fieldCode="AU" term="%22Holinstat+M%22">Holinstat M</searchLink>; Division of Pharmacology, University of Michigan Medical School, Ann Arbor, MI.<br /><searchLink fieldCode="AU" term="%22Hyzy+RC%22">Hyzy RC</searchLink>; Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Michigan Medicine, Ann Arbor, MI.<br /><searchLink fieldCode="AU" term="%22Kaul+DR%22">Kaul DR</searchLink>; Division of Infectious Disease, Department of Internal Medicine, Michigan Medicine, Ann Arbor, MI.<br /><searchLink fieldCode="AU" term="%22Gregg+KS%22">Gregg KS</searchLink>; Division of Infectious Disease, Department of Internal Medicine, Michigan Medicine, Ann Arbor, MI.<br /><searchLink fieldCode="AU" term="%22Lama+VN%22">Lama VN</searchLink>; Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Michigan Medicine, Ann Arbor, MI.<br /><searchLink fieldCode="AU" term="%22Yanik+GA%22">Yanik GA</searchLink>; Blood and Marrow Transplant Program, Michigan Medicine, Ann Arbor, MI; Division of Pediatric Hematology-Oncology, Department of Pediatrics, Michigan Medicine, Ann Arbor, MI. Electronic address: gyanik@med.umich.edu. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%220231335%22">Chest</searchLink> [Chest] 2022 Aug; Vol. 162 (2), pp. 346-355. <i>Date of Electronic Publication: </i>2022 Apr 09. – Name: TypePub Label: Publication Type Group: TypPub Data: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier%22">Elsevier </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>0231335 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1931-3543 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2200123692%22">00123692 </searchLink><i>NLM ISO Abbreviation: </i>Chest <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=35413279 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1016/j.chest.2022.03.046 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 346 Titles: – TitleFull: Defibrotide Therapy for SARS-CoV-2 ARDS. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Frame D – PersonEntity: Name: NameFull: Scappaticci GB – PersonEntity: Name: NameFull: Braun TM – PersonEntity: Name: NameFull: Maliarik M – PersonEntity: Name: NameFull: Sisson TH – PersonEntity: Name: NameFull: Pipe SW – PersonEntity: Name: NameFull: Lawrence DA – PersonEntity: Name: NameFull: Richardson PG – PersonEntity: Name: NameFull: Holinstat M – PersonEntity: Name: NameFull: Hyzy RC – PersonEntity: Name: NameFull: Kaul DR – PersonEntity: Name: NameFull: Gregg KS – PersonEntity: Name: NameFull: Lama VN – PersonEntity: Name: NameFull: Yanik GA IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 08 Text: 2022 Aug Type: published Y: 2022 Identifiers: – Type: issn-electronic Value: 1931-3543 Numbering: – Type: volume Value: 162 – Type: issue Value: 2 Titles: – TitleFull: Chest Type: main |
| ResultId | 1 |
